Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Functional MRI after administration of Gd-based blood pool contrast agents
2007-006724-35Phase 4Active
- Sponsor
- CMIV
- Start
- Jan 2008
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of gadofosveset in None, sponsored by CMIV. Primary endpoint: Optimised MRI sequence with functional contrast. Started Jan 2008; status: active.
02
Drugs
gadofosveset
Beyond the preview
Go deeper on 2007-006724-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-006724-35.